Meningococcus B on college campuses

You may be aware of the recent devastating cases of meningococcus B on college campuses including Princeton, U.C. Santa Barbara and University of Oregon.  Meningococcus B is a strain of this bacteria which is not covered by the current Menactra meningococcal vaccine (which covers types A, C, Y and W-135) already given as part of routine immunizations for our teens.  Recently, the meningococcal B vaccine, which has been used in Europe and Canada, was approved for people aged 10-25 years of age.  The vaccine is a 2 dose series, with the doses at least 1 month apart.  
Meningococcal disease is caused by the bacterium Neisseria meningitidis, also called meningococcus.  About 10% of people have this type of bacteria in the back of their nose and throat with no signs of symptoms of disease.  But sometimes Neisseria meningitidis bacteria can invade the body causing a very serious bacterial disease in the meninges and/or blood.  Meningococcal disease can be a rapidly acting devastating disease and can lead to organ failure, loss of limbs and even death.  
Currently, we anticipate that most insurance companies will not cover this vaccine unless you are in an outbreak situation.   However given the efficacy of this vaccine and the recent cases at various college campuses, we are recommending this vaccine--particularly for young people in college or crowded living environments.   Our office will administer the vaccine to families who want it for their teens/young adults.   Payment will be required at the time of vaccine administration. Please call the office with questions or to schedule an appointment  510 848 2566 x160
Please see the CDC link and manufacturer website link below for more information regarding meningococcal B disease and vaccine.